LUNSUMIO vs ZEVALIN

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 16, 2026·How we rate

Possible drug interaction. LUNSUMIO and ZEVALIN are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	LUNSUMIO	ZEVALIN
Rating	70/100	New
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	MOSUNETUZUMAB-AXGB	IBRITUMOMAB TIUXETAN
Manufacturer	Genentech Inc	Spectrum Pharms
Dosage forms	—	Kit
Drug class	—	—
Boxed warning	Boxed warning	Boxed warning
Treats	Follicular Lymphoma	Follicular Lymphoma, Non-Hodgkin Lymphoma, B-Cell Lymphoma

lunsumio zevalin

Rating

70/100

New

Pharmacy pays

—

Type

Active ingredient

MOSUNETUZUMAB-AXGB

IBRITUMOMAB TIUXETAN

Manufacturer

Genentech Inc

Spectrum Pharms

Dosage forms

—

Kit

Drug class

—

Boxed warning

Treats

Follicular Lymphoma

Follicular Lymphoma, Non-Hodgkin Lymphoma, B-Cell Lymphoma

Frequently asked questions

What is the difference between Lunsumio and Zevalin?

Lunsumio contains Mosunetuzumab-Axgb, while Zevalin contains Ibritumomab Tiuxetan — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.